The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

15626–15650 of 18042

  • SevereFDA (Drugs)·D-952-2014·2014-01-29

    FDA Recalls Estradiol Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Estradiol 0.5 mg tablets because they may have been mislabeled as Nicotine Polacrilex gum.

    Product
    ESTRADIOL, Tablet, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00555089902.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1031-2014·2014-01-29

    KVK-Tech Recalls Hydroxyzine Hydrochloride Tablets Due to Unapproved Ingredient Source

    KVK-Tech, Inc. is recalling 249,096 bottles of Hydroxyzine Hydrochloride tablets because the active pharmaceutical ingredient was sourced from an unapproved supplier.

    Product
    HYDROXYZINE HYDROCHLORIDE — HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-855-2014·2014-01-29

    FDA Recalls MEXILETINE HCL Capsules Due to Potential Labeling Error

    Aidapak Services, LLC is recalling MEXILETINE HCL capsules because they may have been mislabeled as CALCIUM ACETATE. The error could lead to patients receiving the wrong medication.

    Product
    MEXILETINE HCL, Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093873901.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-796-2014·2014-01-29

    Buprenorphine HCL Tablets Recalled for Potential Label Mixup

    Aidapak Services, LLC is recalling Buprenorphine HCL SL tablets due to a potential label mixup with other medications.

    Product
    BUPRENORPHINE HCL SL, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054017613.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-765-2014·2014-01-29

    Aidapak Recalls Atomoxetine Capsules Due to Potential Label Mixup

    Aidapak Services is recalling Atomoxetine HCL capsules because they may be mislabeled as other psychiatric medications.

    Product
    ATOMOXETINE HCL, Capsule, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00002322930.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-867-2014·2014-01-29

    Aidapak Recalls Doxycycline Hyclate Capsules Due to Labeling Error

    Aidapak Services, LLC is recalling Doxycycline Hyclate 100 mg capsules because they may have been mislabeled as Raloxifene HCL 60 mg tablets.

    Product
    DOXYCYCLINE HYCLATE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143314250.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-815-2014·2014-01-29

    FDA Recalls Valsartan Tablets Due to Potential Labeling Mixup

    Aidapak Services, LLC is recalling Valsartan 80 mg tablets because they may have been mislabeled as other prescription drugs.

    Product
    VALSARTAN, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035834.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-841-2014·2014-01-29

    Simvastatin Tablets Recalled for Potential Labeling Error

    Aidapak Services is recalling Simvastatin 5 mg tablets that may be mislabeled as Losartan Potassium 25 mg.

    Product
    SIMVASTATIN, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715298.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-879-2014·2014-01-29

    Aidapak Recalls Lovastatin Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 20 mg Lovastatin tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    LOVASTATIN, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185007201.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-795-2014·2014-01-29

    Aidapak Recalls Acarbose Tablets Due to Potential Labeling Errors

    Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.

    Product
    ACARBOSE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054014025.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-993-2014·2014-01-29

    FDA Recalls Propranolol HCL Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Propranolol HCL 10 mg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.

    Product
    PROPRANOLOL HCL, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00603548221.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-892-2014·2014-01-29

    Thioridazine HCL Tablets Recalled for Potential Label Mixup

    Aidapak Services, LLC is recalling Thioridazine HCL 50 mg tablets because they may have been mislabeled as Guanfacine HCl 1 mg tablets.

    Product
    THIORIDAZINE HCL, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378061601.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-960-2014·2014-01-29

    Aidapak Recalls Lorazepam Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Lorazepam tablets that may have been mislabeled as Tramadol HCl. The repacked drugs were distributed in four western states.

    Product
    LORazepam, Tablet, 0.25 mg (1/2 of 0.5 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591024001.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-850-2014·2014-01-29

    Aidapak Recalls Glyburide Tablets Due to Potential Label Mixup

    Aidapak Services is recalling glyBURIDE MICRONIZED tablets because they may have been mislabeled as digoxin. The error could lead to patients receiving the wrong medication.

    Product
    glyBURIDE MICRONIZED, Tablet, 3 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093803501.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1006-2014·2014-01-29

    Tacrolimus Capsules Recalled for Potential Labeling Mixup

    Aidapak Services is recalling 0.5 mg tacrolimus capsules because they may have been mislabeled as cinacalcet or isosorbide mononitrate.

    Product
    TACROLIMUS, Capsule, 0.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781210201.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-1034-2014·2014-01-29

    Fresenius Kabi Recalls Tranexamic Acid Injection Due to Particulate Matter

    Fresenius Kabi USA is recalling 121,456 vials of Tranexamic Acid Injection USP due to the presence of particulate matter consistent with glass vial delamination.

    Product
    Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061.…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-844-2014·2014-01-29

    Losartan Potassium Tablets Recalled for Potential Label Mixup

    Aidapak Services is recalling Losartan Potassium 25 mg tablets because they may have been mislabeled as Phytonadione 5 mg.

    Product
    LOSARTAN POTASSIUM, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093736498.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-961-2014·2014-01-29

    Aidapak Recalls Loxapine Capsules Due to Potential Sertraline Labeling Error

    Aidapak Services, LLC is recalling Loxapine 5 mg capsules that may have been mislabeled as Sertraline HCL 50 mg tablets. The repacked drugs were distributed in four western states.

    Product
    LOXAPINE, Capsule, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591036901.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-800-2014·2014-01-29

    FDA Recalls Efavirenz Capsules Due to Potential Label Mixup

    Aidapak Services is recalling Efavirenz 200 mg capsules because they may have been mislabeled as metformin HCl 500 mg tablets.

    Product
    EFAVIRENZ, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00056047492.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-755-2014·2014-01-29

    Novartis Recalls Theraflu Flu and Chest Congestion Powder Packets

    Novartis Consumer Health is recalling Theraflu Flu & Chest Congestion powder packets because they may contain foreign substances.

    Product
    Theraflu Flu & Chest Congestion (acetaminophen 1000 mg and guaifenesin 400 mg) powder packets, Natural Citrus flavor, 6-count packets per carton, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 07054-0622, NDC 0043-0483-06, UPC 3 0043-0483-06 1.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-947-2014·2014-01-29

    FDA Recalls Vitamin B Complex Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Vitamin B Complex tablets that may have been mislabeled as Cinacalcet HCl. The repacked drugs were distributed in four western states.

    Product
    VITAMIN B COMPLEX W/C, Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536730001.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-944-2014·2014-01-29

    Aidapak Recalls Niacin TR Tablets Due to Potential Labeling Error

    Aidapak Services, LLC is recalling Niacin TR 750 mg tablets because they may have been mislabeled as Nortriptyline HCL 50 mg capsules.

    Product
    NIACIN TR, Tablet, 750 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536703301.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-832-2014·2014-01-29

    FDA Recalls Sotalol HCL Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling Sotalol HCL 120 mg tablets because they may have been mislabeled as Neomycin Sulfate 500 mg tablets.

    Product
    SOTALOL HCL, Tablet, 120 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106001.
    Category
    Drug
    Distribution
    4 states
  • SevereFDA (Drugs)·D-954-2014·2014-01-29

    FDA Recalls Bromocriptine Mesylate Tablets Due to Potential Label Mixup

    Aidapak Services, LLC is recalling 2.5 mg Bromocriptine Mesylate tablets because they may have been mislabeled as Benazepril HCl or Thioridazine HCl.

    Product
    BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574010603.
    Category
    Drug
    Distribution
    4 states